RNA-seq control (sgNT) and TLE3KO (sgTLE3) cells treated with 10 uM enzalutamide or vehicle
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP193707
下载链接
链接失效反馈官方服务：
资源简介：
To investigate the transcriptional consequences of TLE3 loss in the presence/absence of AR inhibitor enzalutamide in prostate cancer cells, the transcriptomes of WT and TLE3KO cells treated with vehicle or enzalutamide (10 uM) were compared. . Overall design: WT and TLE3KO LNCaP cells treated with 10 uM enzalutamide or vehicle for 5 days (3 replicates)
创建时间：
2020-02-21
